Shortness of Breath and Cardiac Causes

Shortness of breath — the clinical term is dyspnea — ranks among the most common presenting complaints in emergency and outpatient cardiology settings across the United States. This page covers how cardiac disease produces dyspnea, which specific heart conditions are most frequently responsible, and how clinicians distinguish cardiac causes from pulmonary, metabolic, and other origins. Understanding the mechanism matters because the treatment path, the urgency of evaluation, and the long-term prognosis differ sharply depending on the underlying cardiac diagnosis.

Definition and Scope

Dyspnea is defined by the American Thoracic Society (ATS) as "a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity" (ATS Consensus Statement on Dyspnea, 1999). The definition deliberately separates the subjective sensation from the objective finding of labored breathing, a distinction that has direct diagnostic significance: a patient can have severe cardiac dysfunction with minimal reported dyspnea, or report profound breathlessness with only modest measurable impairment.

From a cardiac standpoint, the scope of dyspnea-generating conditions is broad. The major cardiac categories include:

1. Heart failure (systolic and diastolic variants)
2. Coronary artery disease and acute coronary syndromes
3. Cardiac arrhythmias (particularly atrial fibrillation and ventricular tachycardia)
4. Valvular heart disease (especially mitral stenosis and aortic stenosis)
5. Cardiomyopathy (dilated, hypertrophic, and restrictive forms)
6. Pulmonary embolism with right heart strain
7. Pericardial disease (constrictive pericarditis, cardiac tamponade)

The New York Heart Association (NYHA) Functional Classification, maintained by the American Heart Association (AHA NYHA Classification), grades cardiac dyspnea on a four-class scale — from Class I (no symptoms with ordinary activity) to Class IV (symptoms at rest) — and remains the standard framework used in both clinical trials and daily practice.

The broader regulatory and clinical guidance framework for cardiological conditions, including standards governing how cardiac dyspnea is evaluated and documented in US health systems, is addressed in the regulatory context for cardiology.

How It Works

Cardiac dyspnea arises through three principal physiological pathways: elevated intracardiac filling pressures, reduced cardiac output, and reflex or chemoreceptor activation.

Elevated filling pressures are the most common mechanism. When the left ventricle fails to empty adequately — whether due to systolic dysfunction, diastolic stiffness, or outflow obstruction — pressure backs up into the left atrium and subsequently into the pulmonary veins and capillaries. Pulmonary capillary wedge pressure above 18 mmHg (the threshold used in hemodynamic catheterization studies) causes interstitial fluid to accumulate in the lung parenchyma, increasing the work of breathing and stimulating J-receptors in the lung that signal discomfort to the cortex.

Reduced cardiac output limits oxygen delivery to exercising muscle, triggering anaerobic metabolism and lactic acid production earlier than normal. The resulting acidosis stimulates peripheral chemoreceptors, which increase ventilatory drive disproportionately to the patient's perceived exertion level.

Reflex and neurohormonal activation plays a secondary role. In chronic heart failure, elevated circulating norepinephrine and angiotensin II alter central ventilatory control. The resultant heightened respiratory drive persists even at rest in advanced disease, producing the symptom pattern seen in NYHA Class III and IV patients.

Orthopnea — dyspnea that worsens when lying flat — and paroxysmal nocturnal dyspnea (PND) — sudden breathlessness that awakens a sleeping patient — are both products of positional redistribution of fluid into the pulmonary circulation and are considered hallmark cardiac symptoms. The distinction between orthopnea and the positional dyspnea of obstructive lung disease is clinically important: cardiac orthopnea relieves within minutes of sitting upright, whereas lung-disease-related positional changes follow a different pattern tied to secretion movement.

Detailed anatomical context for how cardiac pressures are generated and transmitted is available in the site's overview of cardiology topics.

Common Scenarios

Several discrete clinical presentations account for the majority of cardiac dyspnea encounters in US practice.

Acute decompensated heart failure (ADHF) is responsible for approximately 1 million hospitalizations annually in the United States (Centers for Disease Control and Prevention, Heart Failure Data). The presenting picture typically includes rapid-onset dyspnea, peripheral edema, and rales on auscultation, with chest X-ray showing pulmonary vascular congestion or frank pulmonary edema.

Acute coronary syndrome (ACS), including ST-elevation myocardial infarction (STEMI) and non-ST-elevation MI (NSTEMI), can present with dyspnea as the dominant symptom — particularly in women, older adults, and patients with diabetes, populations in whom chest pain is absent or atypical in a substantial proportion of events. The American College of Cardiology (ACC) and AHA joint guidelines on ACS (2014 AHA/ACC NSTEMI Guideline) identify dyspnea as an ACS equivalent warranting the same urgent evaluation pathway as chest pain.

Atrial fibrillation with rapid ventricular response reduces diastolic filling time and can acutely drop cardiac output by 20–25%, producing sudden breathlessness. This is among the most common arrhythmic causes of dyspnea seen in emergency departments.

Mitral stenosis produces dyspnea through mechanical obstruction at the mitral valve orifice. A normal adult mitral valve area is 4–6 cm²; symptomatic stenosis is generally present when the area falls below 1.5 cm², per ACC/AHA Valvular Heart Disease Guidelines (2021 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease).

Pulmonary embolism with right heart strain causes dyspnea through two mechanisms: dead-space ventilation and acute right ventricular pressure overload. The Wells Score and the PERC rule are standardized risk-stratification tools used in emergency settings to identify which dyspneic patients need CT pulmonary angiography.

Decision Boundaries

Distinguishing cardiac from non-cardiac dyspnea requires integrating history, physical examination, and targeted testing. The following framework reflects standard diagnostic reasoning as codified in ACC/AHA and ATS clinical guidance:

Step 1 — Initial risk stratification. Dyspnea with hemodynamic instability (systolic BP below 90 mmHg, oxygen saturation below 90%, altered mental status) requires immediate evaluation regardless of suspected cause. The ACC/AHA emergency care guidelines treat any combination of dyspnea plus chest pain, syncope, or acute neurological change as a high-acuity presentation.

Step 2 — BNP or NT-proBNP measurement. B-type natriuretic peptide (BNP) and its N-terminal fragment (NT-proBNP) are released by ventricular myocytes under wall stress. A BNP below 100 pg/mL has a negative predictive value above 90% for heart failure as a cause of acute dyspnea, per data from the Breathing Not Properly Multinational Study. Elevated values above 400 pg/mL strongly support a cardiac etiology, though intermediate values (100–400 pg/mL) require additional clinical context. The FDA has cleared BNP and NT-proBNP assays for this diagnostic application (FDA 510(k) database).

Step 3 — Echocardiography. Transthoracic echocardiography (TTE) differentiates systolic dysfunction (reduced ejection fraction), diastolic dysfunction (preserved ejection fraction with elevated filling pressures), valvular lesions, pericardial effusion, and regional wall motion abnormalities. The American Society of Echocardiography (ASE) publishes guidelines on grading diastolic dysfunction (ASE 2016 Diastolic Function Guidelines) that provide a structured four-variable algorithm for identifying elevated filling pressures — a key diagnostic target in cardiac dyspnea evaluation.

Cardiac versus pulmonary contrast. The cardinal distinguishing features are summarized below:

Step 4 — Condition-specific investigation. Once a cardiac category is suspected

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)